Objectives: To assess
whether type-2 diabetics had increased levels of local and systemic
pro-inflammatory mediators and whether those higher levels are associated with
enhanced clinical gingival inflammation compared to non-diabetics.
Material and Methods: A
cross-sectional database consisting of 726 male and female non-smokers, aged 53
to 74 years was used. Gingival crevicular fluid (GCF) levels of IL-1b and PGE2
and serum level of IL-6 were measured using ELISA. All participants had
no probing pocket depths (PD) > 3mm. Participants with bleeding on probing (BOP) in <10% of sites were classified as healthy, while those with BOP of 10% or more were
defined to have gingivitis.
Results: Approximately 53% (n=385) of the sample had gingivitis, and 11% (n=80) had type-2 diabetes. The
mean age-adjusted level of GCF-IL-1b was significantly elevated in diabetic compared
to non-diabetic groups (GCF-IL-1b, p=0.048; but not serum IL-6, p=0.14 or GCF-PGE2, p=0.98). All mediator levels were higher in participants
with gingivitis regardless of diabetic status, and the difference was
significant except serum IL-6 in the non-diabetic group. The significance of
the interaction between diabetes and GCF-IL-1b or diabetes and serum IL-6 on
gingivitis were borderline (p=0.09, p=0.065, respectively). Adjusted odds
ratios for the association between proinflammatory mediators and gingivitis
case status stratified by diabetic status are shown below.
Mediators | No diabetes | Diabetes | (separate models) | OR (95%CI)* | Serum IL-6 | 1.01 (0.94 –1.09) | 1.61 (1.08 – 2.41) | GCF-IL-1b (100 ng/mL) | 1.57 (1.26 – 1.95) | 3.19 (1.48 – 6.87) | GCF-PGE2 (100 ng/mL) | 1.22 (1.10 – 1.35) | 1.73 (1.11 – 2.70) |
Reference group: healthy individuals (n=341)
*Controlling for age, gender, education, HDL-cholesterol,
fasting glucose, waist-hip ratio, hypertension, BMI, plaque scores, study center
Conclusions: Type-2
diabetes may increase the host inflammatory response to the oral biofilm, which
may enhance gingivitis. Furthermore, systemic inflammation (serum IL-6) is
associated with gingivitis among diabetics.
|